A Study to Compare Pharmacokinetics (PK) of Etrolizumab Administered Subcutaneously by a Prefilled Syringe With Needle Safety Device (PFS-NSD) or an Auto-injector (AI)
Clinical trial NCT02996019 · COMPLETED
Trial details
- NCT number
- NCT02996019
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-07
- Primary completion
- 2018-04-09
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.